Copyright Reports & Markets. All rights reserved.

Urology Devices Global Market

Request for Sample of this report
Buy now

1 EXECUTIVE SUMMARY 35

    2 INTRODUCTION 43

    • 2.1 KEY TAKE AWAYS 43
    • 2.2 REPORT DESCRIPTION 44
    • 2.3 MARKETS COVERED 45
    • 2.4 STAKEHOLDERS 49
    • 2.5 RESEARCH METHODOLOGY 50
      • 2.5.1 MARKET SIZE ESTIMATION 51
      • 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 54
      • 2.5.3 SECONDARY SOURCES 55
      • 2.5.4 PRIMARY SOURCES 55
      • 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 56
      • 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 57
      • 2.5.7 ASSUMPTIONS 57

    3 MARKET ANALYSIS 59

    • 3.1 INTRODUCTION 59
    • 3.2 MARKET SEGMENTATION 60
    • 3.3 FACTORS INFLUENCING MARKET 62
      • 3.3.1 DRIVERS AND OPPORTUNITIES 63
        • 3.3.1.1 Increase in aging population and subsequent rise in incidence of kidney and urology diseases 63
        • 3.3.1.2 Increased demand for minimally invasive surgical procedures 63
        • 3.3.1.3 Rising awareness of urology device due to faster recovery time and less

      hospital stays 64

      • 3.3.1.4 Favorable reimbursement policies 65
      • 3.3.1.5 Market expansion opportunities in emerging nations 65
    • 3.3.2 RESTRAINTS AND THREATS 66
      • 3.3.2.1 Patient safety risks due to chances of infections and other complications while using urology devices 66
      • 3.3.2.2 Lack of skilled professionals in handling urology devices 67
      • 3.3.2.3 Soaring cost of urology devices 67
      • 3.3.2.4 Stringent regulatory bodies guiding the urology devices manufacturers 68
    • 3.3.3 REIMBURSEMENT SCENARIO 69
    • 3.3.4 REIMBURSEMENT TABLE 69
  • 3.4 REGULATORY AFFAIRS 73
    • 3.4.1 U.S. 73
    • 3.4.2 EUROPE 74
    • 3.4.3 INDIA 74
    • 3.4.4 CHINA 75
    • 3.4.5 JAPAN 75
  • 3.5 TECHNOLOGICAL ADVANCEMENTS AND ON GOING CLINICAL TRIALS 76
    • 3.5.1 ADVANCES IN LAPAROSCOPIC UROLOGIC SURGERICAL PROCEDURE 76
    • 3.5.2 ROBOTIC ASSITED UROLOGY DEVICES 77
    • 3.5.3 LASER ASSISTED UROLOGY DEVICES 77
    • 3.5.4 UROLOGY DEVICES UNDER CLINICAL TRIAL 78
  • 3.6 SUPPLY CHAIN ANALYSIS 83
  • 3.7 PORTER’S FIVE FORCE ANALYSIS 87
    • 3.7.1 THREAT OF NEW ENTRANTS 88
    • 3.7.2 THREAT OF SUBSTITUTES 89
    • 3.7.3 RIVALRY AMONG EXISTING COMPETITORS 90
    • 3.7.4 BARGAINING POWER OF SUPPLIERS 90
    • 3.7.5 BARGAINING POWER OF BUYERS 90
  • 3.8 MARKET SHARE ANALYSIS 92
    • 3.8.1 UROLOGY DEVICES GLOBAL MARKET SHARE ANALYSIS 92
    • 3.8.2 UROLOGY ENDOSCOPES GLOBAL MARKET SHARE ANALYSIS 95
    • 3.8.3 INCONTINENCE CARE DEVICES GLOBAL MARKET SHARE ANALYSIS 97
    • 3.8.4 DIALYSIS DEVICES GLOBAL MARKET SHARE ANALYSIS 99
    • 3.8.5 HEMODIALYSIS DEVICES GLOBAL MARKET SHARE ANALYSIS 102
    • 3.8.6 PERITONEAL DIALYSIS DEVICES GLOBAL MARKET SHARE ANALYSIS 105

    • 4 UROLOGY DEVICES GLOBAL MARKET, BY PRODUCTS 107

    • 4.1 INTRODUCTION 107
    • 4.2 UROLOGY ENDOSCOPES 111
      • 4.2.1 ENDOSCOPE DEVICES 116
        • 4.2.1.1 Nephroscopes 119
        • 4.2.1.2 Cystoscopes 121
        • 4.2.1.3 Resectoscopes 123
        • 4.2.1.4 Laparoscopes 124
      • 4.2.2 ENDOVISION SYSTEMS 128
        • 4.2.2.1 Endoscopic cameras 132
        • 4.2.2.2 Digital documentation systems 134
        • 4.2.2.3 Endoscopic light sources 136
        • 4.2.2.4 Monitors and display systems 137
        • 4.2.2.5 Video converters and processors 139
      • 4.2.3 PERIPHERAL INSTRUMENTS 142
        • 4.2.3.1 Insufflators 145
        • 4.2.3.2 Fluid management systems 147
      • 4.2.4 CONSUMABLES 149
        • 4.2.4.1 Biopsy forceps 153
        • 4.2.4.2 Graspers 154
        • 4.2.4.3 Snares 155
        • 4.2.4.4 Trocars 156
        • 4.2.4.5 Others 158
    • 4.3 URODYNAMIC SYSTEMS 161
      • 4.3.1 CYSTOMETERS 166
      • 4.3.2 ELECTROMYOGRAPHS 167
      • 4.3.3 VIDEO URODYNAMIC SYSTEMS 168
      • 4.3.4 UROFLOWMETRY EQUIPMENT 169
      • 4.3.5 AMBULATORY URODYNAMIC SYSTEMS 170
      • 4.3.6 DISPOSABLES 171
        • 4.3.6.1 Transducer sets & infusion 175
        • 4.3.6.2 Water filled catheters 176
        • 4.3.6.3 Air filled catheters 177
        • 4.3.6.4 Perfusion pump tubing 179
    • 4.4 DIALYSIS DEVICES 180
      • 4.4.1 HEMODIALYSIS DEVICES 185
        • 4.4.1.1 Hemodialysis machines 189
        • 4.4.1.2 Hemodialysis consumables & accessories 192
      • 4.4.2 PERITONEAL DIALYSIS DEVICES 199
        • 4.4.2.1 Peritoneal dialysis machines 205
        • 4.4.2.2 Peritoneal dialysis concentrate/dialysate 207
        • 4.4.2.3 Peritoneal dialysis catheters 209
        • 4.4.2.4 Peritoneal dialysis transfer sets 211
        • 4.4.2.5 Other peritoneal dialysis products 213
    • 4.5 STONE MANAGEMENT DEVICES 214
      • 4.5.1 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) 219
      • 4.5.2 URETEROSCOPES/INTRACORPOREAL LITHOTRIPSY 220
      • 4.5.3 PERCUTANEOUS NEPHROLITHOTRIPSY (PCNIL) 222
      • 4.5.4 OTHERS 224
    • 4.6 BENIGN PROSTATIC HYPERPLASIA DEVICES 228
      • 4.6.1 TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) 232
      • 4.6.2 TRANSURETHRAL INCISION OF THE PROSTATE (TUIP) 233
      • 4.6.3 TRANSURETHRAL HOLMIUM NEEDLE ABLATION OF THE PROSTATE 235
      • 4.6.4 TRANSURETHRAL MICROWAVE THERAPY (TUMT) 236
      • 4.6.5 INTERSTITIAL LASER COAGULATION DEVICE (ILC) 237
      • 4.6.6 PROSTATIC STENTS 238
      • 4.6.7 OTHERS 239
    • 4.7 INCONTINENCE CARE DEVICES 241
      • 4.7.1 DISPOSABLE 246
        • 4.7.1.1 Incontinence bags 249
        • 4.7.1.2 Clamps and cleaners 251
        • 4.7.1.3 Anal irrigation system 253
        • 4.7.1.4 Incontinence catheter 254
        • 4.7.1.5 Pessaries 256
      • 4.7.2 IMPLANTS 257
        • 4.7.2.1 Sacral nerve stimulation (SNS) 260
        • 4.7.2.2 Tibial nerve stimulation (TNS) 262
        • 4.7.2.3 Sphincters 263
        • 4.7.2.4 Slings 265
    • 4.8 ERECTILE DYSFUNCTION DEVICES 266
      • 4.8.1 VACUUM CONSTRICTION DEVICE/PENIS PUMP 270
      • 4.8.2 PENILE IMPLANTS/PENILE PROSTHESIS 272
      • 4.8.3 OTHERS 273
    • 4.9 NEPHROSTOMY DEVICES 274
      • 4.9.1 NEPHROSTOMY CATHETERS 278
      • 4.9.2 GUIDEWIRES 280
      • 4.9.3 DRAINAGE TUBES 281
      • 4.9.4 BALLOON DILATORS 282
      • 4.9.5 OTHERS 283
    • 4.10 UROLOGY BLADDER SCANNERS 284

    5 UROLOGY DEVICES GLOBAL MARKET, BY APPLICATIONS 287

    • 5.1 INTRODUCTION 287
    • 5.2 KIDNEY DISEASE 290
    • 5.3 URINARY STONES 293
    • 5.4 BENIGN PROSTATIC HYPERPLASIA 295
    • 5.5 URINARY INCONTINENCE 297
    • 5.6 PELVIC ORGAN PROLAPSE 299
    • 5.7 UROLOGICAL CANCER 301
    • 5.8 ERECTILE DYSFUNCTION 303
    • 5.9 OTHERS 305

    6 UROLOGY DEVICES GLOBAL MARKET, BY END-USERS 308

    • 6.1 INTRODUCTION 308
    • 6.2 HOSPITALS 311
    • 6.3 CLINICS 312
    • 6.4 HOME HEALTHCARE 314
    • 6.5 AMBULATORY SURGICAL CENTERS 315
    • 6.6 ACADEMIC & DIAGNOSTIC LABORATORIES 317
    • 6.7 OTHERS 319

    7 UROLOGY DEVICES GLOBAL MARKET, BY GEOGRAPHY 321

    • 7.1 INTRODUCTION 321
    • 7.2 NORTH AMERICA 322
      • 7.2.1 UNITED STATES (U.S.) 346
      • 7.2.2 OTHERS 350
    • 7.3 EUROPE 354
      • 7.3.1 GERMANY 379
      • 7.3.2 U.K. 381
      • 7.3.3 FRANCE 383
      • 7.3.4 OTHERS 387
    • 7.4 ASIA-PACIFIC (APAC) 389
      • 7.4.1 INDIA 414
      • 7.4.2 CHINA 417
      • 7.4.3 JAPAN 420
      • 7.4.4 OTHERS 422
    • 7.5 REST OF WORLD (ROW) 426
      • 7.5.1 BRAZIL 449
      • 7.5.2 REST OF LATIN AMERICA 451
      • 7.5.3 MIDDLE EAST & OTHERS 453

    8 COMPANY DEVELOPMENTS 456

    • 8.1 INTRODUCTION 456
      • 8.1.1 NEW PRODUCT LAUNCHES AS A MAJOR GROWTH STRATEGY OF

    UROLOGY DEVICES PLAYERS 456

    • 8.2 NEW PRODUCT LAUNCHES 458
    • 8.3 MERGERS & ACQUISITIONS 463
    • 8.4 APPROVALS 466
    • 8.5 OTHER DEVELOPMENTS 467
    • 8.6 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 469

    9 COMPANY PROFILES 470

    • 9.1 BAXTER INTERNATIONAL, INC. 470
      • 9.1.1 OVERVIEW 470
      • 9.1.2 FINANCIALS 471
      • 9.1.3 PRODUCT PORTFOLIO 473
      • 9.1.4 KEY DEVELOPMENTS 477
      • 9.1.5 BUSINESS STRATEGY 479
      • 9.1.6 SWOT ANALYSIS 480
    • 9.2 B.BRAUN MELSUNGEN AG 481
      • 9.2.1 OVERVIEW 481
      • 9.2.2 FINANCIALS 482
      • 9.2.3 PRODUCT PORTFOLIO 485
      • 9.2.4 KEY DEVELOPMENTS 487
      • 9.2.5 BUSINESS STRATEGY 488
      • 9.2.6 SWOT ANALYSIS 489
    • 9.3 BOSTON SCIENTIFIC CORPORATION 490
      • 9.3.1 OVERVIEW 490
      • 9.3.2 FINANCIALS 491
      • 9.3.3 PRODUCT PORTFOLIO 494
      • 9.3.4 KEY DEVELOPMENTS 499
      • 9.3.5 BUSINESS STRATEGY 500
      • 9.3.6 SWOT ANALYSIS 501
    • 9.4 COOK MEDICAL 502
      • 9.4.1 OVERVIEW 502
      • 9.4.2 FINANCIALS 503
      • 9.4.3 PRODUCT PORTFOLIO 503
      • 9.4.4 KEY DEVELOPMENTS 506
      • 9.4.5 BUSINESS STRATEGY 507
      • 9.4.6 SWOT ANALYSIS 508
    • 9.5 COLOPLAST 509
      • 9.5.1 OVERVIEW 509
      • 9.5.2 FINANCIALS 510
      • 9.5.3 PRODUCT PORTFOLIO 512
      • 9.5.4 KEY DEVELOPMENTS 515
      • 9.5.5 BUSINESS STRATEGY 516
      • 9.5.6 SWOT ANALYSIS 517
    • 9.6 C.R.BARD INC. 518
      • 9.6.1 OVERVIEW 518
      • 9.6.2 FINANCIALS 519
      • 9.6.3 PRODUCT PORTFOLIO 521
      • 9.6.4 KEY DEVELOPMENTS 523
      • 9.6.5 BUSINESS STRATEGY 524
      • 9.6.6 SWOT ANALYSIS 525
    • 9.7 FRESENIUS SE & CO 526
      • 9.7.1 OVERVIEW 526
      • 9.7.2 FINANCIALS 527
      • 9.7.3 PRODUCT PORTFOLIO 530
      • 9.7.4 KEY DEVELOPMENTS 532
      • 9.7.5 BUSINESS STRATEGY 533
      • 9.7.6 SWOT ANALYSIS 534
    • 9.8 KARL STORZ GMBH & CO. KG 535
      • 9.8.1 OVERVIEW 535
      • 9.8.2 FINANCIALS 536
      • 9.8.3 PRODUCT PORTFOLIO 536
      • 9.8.4 KEY DEVELOPMENTS 537
      • 9.8.5 BUSINESS STRATEGY 537
      • 9.8.6 SWOT ANALYSIS 538
    • 9.9 NIPRO CORPORATION 539
      • 9.9.1 OVERVIEW 539
      • 9.9.2 FINANCIALS 540
      • 9.9.3 PRODUCT PORTFOLIO 542
      • 9.9.4 KEY DEVELOPMENTS 544
      • 9.9.5 BUSINESS STRATEGY 544
      • 9.9.6 SWOT ANALYSIS 545
    • 9.10 OLYMPUS CORPORATION 546
      • 9.10.1 OVERVIEW 546
      • 9.10.2 FINANCIALS 547
      • 9.10.3 PRODUCT PORTFOLIO 549
      • 9.10.4 KEY DEVELOPMENTS 552
      • 9.10.5 BUSINESS STRATEGY 552

    Urology devices are medical devices used for diagnosis and treatment of kidney and urology diseases. The emerging trend in urological surgical procedures is the preference for use of minimally invasive devices due to advantages such as fewer incisions, faster recovery rate and less hospital stays compared to open surgical intervention. Present trend in this market is development and usage of next-generation urology devices like laser and robotic assisted devices to make surgical procedure even more simpler with better outcomes like greater precision and accuracy, visualization of intricate surgical sites and quick rehabilitation.
    According to IQ4I analysis, the Urology Devices Global market is expected to reach $33,966.5 million by 2023 growing at mid single digit CAGR. Urology devices market is segmented on the basis of products, applications, end-users and geography. Products are further segmented into Urinary Endoscopes, Dialysis devices, Urodynamic systems, Stone management devices, Benign prostate hyperplasia devices, Incontinence care devices, urinary catheters, and Intrauterine devices. Applications are segmented into kidney disease, urinary stones, benign prostatic hyperplasia, urinary incontinence, pelvic organ prolapsed, urological cancer, erectile dysfunction and others (interstitial cystitis). End-users are further classified into hospitals, clinics, ambulatory surgical centers, home healthcare and others (dialysis centers and kidney care centers).
    Among the urology devices products market, dialysis segment holds the largest share and incontinence care devices is expected to be the fastest growing segment with a mid single digit CAGR. In applications market, kidney disease holds the largest share of the market and urinary incontinence is expected to grow with a strong mid single digit CAGR. In end- users, hospitals is the largest and fastest growing segment. Geographically, Europe is the largest market, followed by Europe and Asia Pacific. The APAC region is the fastest growing region with a high single digit CAGR from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the urology devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
    The urology devices market is expected to grow at a single digit CAGR from 2016 to 2023. Increase in aging population and subsequent rise in incidence of urology and kidney disorders, increasing demand for minimally invasive surgical procedures and favourable reimbursement policies are the factors driving the market growth. Increasing hospital investments to improve infrastructure for urological disease treatment, rising awareness about urology devices due to its faster recovery, less hospital stays and market expansion opportunities in emerging nations are expected to offer potential opportunities.
    However various factors like patient safety risks due to chances of infection and other complications while using urology devices, lack of skilled professionals in handling urology devices limits the growth of Urology devices global market. The threats for the urology devices market include soaring urology device cost and stringent regulations guiding urology manufacturers.
    The urology devices global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the urology devices market are B Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Cook Medical (U.S.), Coloplast (Denmark), Nipro Corporation (Japan), Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (U.S.), C.R. Bard (Inc U.S.), Olympus Corporation (Japan) and KARL STORZ GmbH & Co. KG (Germany).
    The report provides an in depth market analysis of the above mentioned segments across the following regions:
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)
    Buy now